Influence of acute rejection episodes, HLA matching, and donor/recipient phenotype on the development of 'Early' transplant-associated coronary artery disease

Circulation

Volumn 96, Issue 9 SUPPL., 1997, Pages

  Hornick, Philip ^a,b   Smith, John ^a   Pomerance, Ariela ^a   Mitchell, Andrew ^a   Banner, Nick ^a   Rose, Marlene ^a   Yacoub, Magdi ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Coronary disease; Immunology; Rejection; Risk factors; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DR ANTIGEN; PREDNISONE;

ACUTE DISEASE; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; AUTOPSY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; GRAFT REJECTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE;

ACUTE DISEASE; ADULT; CORONARY DISEASE; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; PHENOTYPE;

EID: 0342601377     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Billingham M. Cardiac transplant atherosclerosis. Transplant Proc. 1987;19(suppl 5):19-25.
2. Gao S, Schroeder J, Alderman EL, Hunt SA, Valantine HA, Wiederhold V, Stinson EB. Prevalence of accelerated coronary artery disease in heart transplant survivors: Comparison of cyclosporine and azathioprine regimens. Circulation. 1989;80(suppl III):100-105.
3. Uretsky B, Murali S, Reddy P, Rabin B, Lee A, Bartley P, Griffith B, Hardesty R, Trento A, Bahnson H. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisolone. Circulation. 1987;76:827-833.
4. Gao A, Alderman E, Schroeder J, Silverman J, Hunt S. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol. 1988;12:334-340.
5. Hess J, Hastillo A, Mohanakumar T, Cowley MJ, Vetrovac G, Szentpeterey S, Wolfgang TC, Lower RR. Accelerated atherosclerosis in cardiac transplantation: role of cytotoxic B-cell antibodies and hyperlipidaemia. Circulation. 1983;68(suppl 2):94-101.
6. Zerbe T, Uretsky B, Kormos R, Armitage J, Wolyn T, Griffith B, Hardesty R, Duquesnoy R. Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen. J Heart Lung Transplant. 1992;11:S104-S110.
7. Hosenpud J, Shipley J, Waper C. Cardiac allograft vasculopathy: Current concepts, recent developments and future directions. J Heart Lung Transplant. 1992;11:9-23.
8. Cramer D, Chapman F, Wu G, Hamaha J, Quian S, Makowka L. Cardiac transplantation in the rat. II. Alteration of the severity of donor graft arteriosclerosis by modulation of the host immune response. Transplantation. 1990;50:554-558.
9. Shin Y, Adams D, Wyner L, Akalin E, Sayegh M, Karnovsky M. Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model. Transplantation. 1995;59:1647-1653.
10. Shi C, Lee W, He Q, Zhang D, Fletcher DL, Newell JB, Haber E. Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci U S A. 1996;93:4051-4056.
11. Dunn M, Crisp S, Rose M, Taylor P, Yacoub M. Anti-endothelial antibodies and coronary artery disease after cardiac transplantation. Lancet. 1992;339:1566-1570.
12. Crisp S, Dunn M, Rose M, Taylor P, Yacoub M. Antiendothelial antibodies after heart transplantation: the accelerating factor in transplant associated coronary artery disease. J Heart Lung Transplant. 1994;13:81-92.
13. Suciu-Foca N, Reed E, Marboe C, Harris P, Yu PX, Juo YC, Ho E, Rose E, Reernstomak K, King DW. The role of anti-HLA antibodies in heart transplantation. Transplantation. 1991;51:716-724.
14. Reed E, Hong B, Ho E, Harris P, Weinberger J, Suciu-Foca N. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation. 1996;61:566-572.
15. Gao SZ, Schroeder JS, Alderman EL, Hunt SA, Silverman JF, Wiederhold V, Stinson EB. Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient. Circulation. 1987;76:56-61.
16. Barbir M, Kushwaha S, Hunt B, Macken A, Thompson GR, Mitchell A, Robinson D, Yacoub M. Lipoprotein (a) and accelerated coronary artery disease in cardiac transplant patients. Lancet. 1992;340:1500-1502.
17. Paul L, Tilney N. Alloantigen-dependent events in chronic rejection. In: Tilney N, Strom T, Paul L, eds. Transplantation Biology. Philadelphia, PA: Lippincott-Raven: 1996:567-575.
18. Catanzo-Nordin M. Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility. J Heart Lung Transplant. 1992;11:S90-S103.
19. Smith J, Rose M, Pomerance A, Burke M, Yacoub M. Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching. Lancet. 1995;346: 1318-1322.
20. Brand D, Ray J, Hare D, Kayhoe D, McClelland J. Preliminary trials towards standardisation of leukocyte typing. In: Terasaki P, ed. Histocompatibility Testing. Copenhagen: Munksgaard; 1970: 357-367.
21. Van Rood J, Van Leeuwen A, Ploem J. Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants. Nature. 1976;262:795-797.
22. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 1992;39:225-235.
23. Buyse I, Decorte R, Baens M, Cuppens H, Semank G, Emonds MP, Marynth P, Cassiman JJ. Rapid DNA typing of Class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens. 1993;41:1-14.
24. Cecka J. Outcome statistics of renal transplants with an emphasis on long-term survival. Clin Transplant. 1994;8:324-327.
25. Matas A, Gillingham K, Payne W, Najarian J. The impact of an acute rejection episode on long term survival of the renal graft. Transplantation. 1994;57:857-859.
26. Billingham M. Graft coronary disease: the lesions and the patients. Transplant Proc. 1989;21:3665-3666.
27. Billingham M. Pathobiology and aetiology of chronic rejection of the heart. Clin Transplantation. 1994;8:289-292.
28. Billingham M, Cary N, Hammond M, et al. A working formulation for the standardisation of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Transplant. 1990;9:587-593.
29. Stovin PG, Sharples LD, Schofield PM, Cary NR, Mullins PA, English TA, Wallwork J, Large SR. Lack of association between endomyocardial evidence of rejection in the first six months and the later development of transplant coronary artery disease. J Heart Lung Transplant. 1993;12:110-116.
30. Narrod J, Kormos R, Armitage J, Hardesty R, Ladowski J, Griffith B. Acute rejection and coronary artery disease in long-term survivors of heart transplantation. J Heart Transplant. 1989;5:418-421.
31. Stovin P, Sharples P, Hutter J, Wallwork J, English T. Some prognostic factors of the development of transplant-related coronary artery disease in human cardiac allografts. J Heart Lung Transplant. 1991;1:38-44.
32. Terasaki P, Cecka J, Gjertson D, Cho Y, Takemoto S, Cohn M. A ten year prediction for kidney transplant survival. In: Teresaki PI, Cecka JM, eds. Clinical Transplants 1992. Los Angeles, CA: UCLA Tissue Typing Laboratory; 1993:501-512.
33. Cunningham D, Crisp S, Barbir M, Lazem F, Dunn M, Yacoub M. Donor ACE gene polymorphism: a genetic risk factor for accelerated coronary sclerosis following cardiac implantation. Eur Heart J. 1997. In press.
34. Auchinloss HJ, Sutan H. Antigen processing and presentation in transplantation. Curr Opin Immunol. 1996;8:681-687.
35. Lechler R, Batchelor J. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp. Med. 1982;155:31-41.
36. Hornick P, Lechler R. Direct and indirect pathways of allorecognition: relevance to acute and chronic allograft rejection. Nephrol Dial Transplant. In press.